Casdin Capital as of June 30, 2022
Portfolio Holdings for Casdin Capital
Casdin Capital holds 40 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eqrx | 15.7 | $185M | 40M | 4.69 | |
| Alnylam Pharmaceuticals (ALNY) | 9.9 | $117M | 805k | 145.85 | |
| Biolife Solutions Com New (BLFS) | 8.8 | $105M | 7.6M | 13.81 | |
| Relay Therapeutics (RLAY) | 5.8 | $68M | 4.1M | 16.75 | |
| Maxcyte (MXCT) | 5.6 | $66M | 14M | 4.73 | |
| Blueprint Medicines (BPMC) | 4.9 | $58M | 1.2M | 50.51 | |
| Somalogic Class A Com | 4.7 | $56M | 12M | 4.52 | |
| Fate Therapeutics (FATE) | 4.4 | $52M | 2.1M | 24.78 | |
| Sarepta Therapeutics (SRPT) | 4.1 | $49M | 650k | 74.96 | |
| Verve Therapeutics (VERV) | 4.1 | $48M | 3.1M | 15.28 | |
| Revolution Medicines (RVMD) | 3.9 | $46M | 2.4M | 19.49 | |
| Denali Therapeutics (DNLI) | 3.7 | $44M | 1.5M | 29.43 | |
| Century Therapeutics (IPSC) | 2.3 | $27M | 3.2M | 8.40 | |
| Absci Corp (ABSI) | 2.2 | $26M | 7.7M | 3.32 | |
| Global Blood Therapeutics In | 2.2 | $26M | 800k | 31.95 | |
| Sema4 Holdings Corp Com Cl A | 1.8 | $21M | 16M | 1.26 | |
| Tenaya Therapeutics (TNYA) | 1.7 | $20M | 3.6M | 5.63 | |
| EXACT Sciences Corporation (EXAS) | 1.5 | $18M | 450k | 39.39 | |
| Twist Bioscience Corp (TWST) | 1.5 | $18M | 500k | 34.96 | |
| Agios Pharmaceuticals (AGIO) | 1.5 | $17M | 785k | 22.17 | |
| Tango Therapeutics (TNGX) | 1.3 | $16M | 3.5M | 4.53 | |
| Beam Therapeutics (BEAM) | 1.2 | $15M | 375k | 38.71 | |
| Guardant Health (GH) | 0.9 | $11M | 273k | 40.34 | |
| Karuna Therapeutics Ord | 0.9 | $11M | 85k | 126.51 | |
| 2seventy Bio Common Stock (TSVT) | 0.7 | $8.1M | 615k | 13.20 | |
| Abcellera Biologics (ABCL) | 0.7 | $8.0M | 750k | 10.65 | |
| Exscientia Ads (EXAI) | 0.6 | $7.2M | 664k | 10.89 | |
| Mirati Therapeutics | 0.6 | $6.5M | 97k | 67.13 | |
| Monte Rosa Therapeutics (GLUE) | 0.4 | $4.9M | 511k | 9.67 | |
| Celldex Therapeutics Com New (CLDX) | 0.4 | $4.4M | 165k | 26.96 | |
| Pmv Pharmaceuticals (PMVP) | 0.4 | $4.3M | 300k | 14.25 | |
| Sangamo Biosciences (SGMO) | 0.4 | $4.1M | 1.0M | 4.14 | |
| 4d Molecular Therapeutics In (FDMT) | 0.3 | $3.9M | 556k | 6.98 | |
| Singular Genomics Systems In (OMIC) | 0.3 | $3.3M | 866k | 3.82 | |
| Magenta Therapeutics | 0.2 | $2.9M | 2.4M | 1.20 | |
| Oric Pharmaceuticals (ORIC) | 0.2 | $2.7M | 602k | 4.48 | |
| Invitae (NVTAQ) | 0.2 | $2.5M | 1.0M | 2.44 | |
| Science 37 Holdings | 0.0 | $452k | 225k | 2.01 | |
| Kronos Bio (KRON) | 0.0 | $451k | 124k | 3.64 | |
| Lianbio Sponsored Ads (LIANY) | 0.0 | $446k | 206k | 2.16 |
